Oxacillin
Oxacillin for Injection, USP
Approved
Approval ID
af2dccac-98c8-488f-a133-6374b3ca8dba
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 29, 2020
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Oxacillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-813
Application NumberANDA206198
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJuly 29, 2020
FDA Product Classification
INGREDIENTS (2)
OXACILLIN SODIUMActive
Quantity: 1 g in 20 mL
Code: G0V6C994Q5
Classification: ACTIM
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
Oxacillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-812
Application NumberANDA206198
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJuly 29, 2020
FDA Product Classification
INGREDIENTS (2)
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
OXACILLIN SODIUMActive
Quantity: 2 g in 20 mL
Code: G0V6C994Q5
Classification: ACTIM